Stamford, CT -- (SBWIRE) -- 01/18/2014 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Delcath Systems, Inc.(NASDAQ:DCTH), Hemispherx BioPharma, Inc(NYSEMKT:HEB), Generex Biotechnology Corporation(OTCMKTS:GNBT), Netlist, Inc.(NASDAQ:NLST)
Delcath Systems, Inc.(NASDAQ:DCTH) opened the session at $0.36, remained amid the day range of $0.33 - $0.38, and closed the session at $0.359. The stock showed a negative performance of -7.82% in previous trading session. The stock gained a volume of 13.03 million shares and the average volume of the stock remained 5.82 million shares. Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology.
Will DCTH Get Buyers Even After The Recent Rally? Find Out Here
Hemispherx BioPharma, Inc(NYSEMKT:HEB) traded with volume of 8.19 million shares in the prior session and the average volume of the stock remained 3.56 million shares. The 52 week range of the stock remained $0.18 - $0.50. The stock showed a positive movement of +8.55% and closed its session at $0.412. The market capitalization of the stock remained 69.17 million. Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Will HEB Continue To Move Higher? Find Out Here
Generex Biotechnology Corporation(OTCMKTS:GNBT) exchanged 8.03 million shares and the average volume remained 5.52 million shares. The stock escalated +2.38% and closed the session at $0.0430. The beta of the stock remained 2.12 and the EPS of the stock remained -0.02. The shares outstanding of the stock remained 580.33 million. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
For How Long GNBT will fight for Profitability? Read This Trend Analysis report
Netlist, Inc.(NASDAQ:NLST) gained volume of 7.52 million shares, while the average volume remained 244,856.00 shares. The stock advanced +1.54% and finished the session Friday at $1.32. The EPS of the stock remained -0.44. The one month of the stock was 67.09% and three month trend remained positive 60.98%. Netlist, Inc. designs, manufactures, and sells intelligent memory subsystems for the datacenter server, high-performance computing, and communications markets worldwide.
For How Long NLST’s Gloss will Attract Investors ? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)